Stock Chart
AMRX
Type: SELL growth_1yr
Strike: $13
Premium: $1.45
Expiry: Jun 18, 2026
Target: $12
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About AMRX - Amneal Pharmaceuticals, Inc. Class A Common Stock
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental …
Key Statistics
More AMRX Analysis
This AMRX stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track AMRX's price movements with trendlines, gamma walls, and key support/resistance levels.